Localization of M2 muscarinic acetylcholine receptor protein in cholinergic and non-cholinergic terminals in rat hippocampus

被引:72
作者
Rouse, ST [1 ]
Edmunds, SM [1 ]
Yi, H [1 ]
Gilmor, ML [1 ]
Levey, AI [1 ]
机构
[1] Emory Univ, Sch Med, Dept Neurol, WMB, Atlanta, GA 30322 USA
关键词
muscarinic; hippocampus; immunocytochemistry; vesicular acetylcholine; presynaptic; autoreceptor;
D O I
10.1016/S0304-3940(00)01011-9
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The muscarinic receptor family (M-1-M-4) mediates cholinergic modulation of hippocampal transmission. Pharmacological and physiological studies have indicated that a presynaptic receptor on cholinergic terminals plays a key role in regulating ACh release, although the molecular identity of this subtype is uncertain, In this study, the localization of the M-2 receptor is described in detail for the pyramidal cell layer in the CAI region of the hippocampus. Electron microscopic analysis of M-2 immunoreactivity in this area revealed mainly presynaptic expression of this subtype. Double-labeling experiments using antibodies to M-2 and to the vesicular acetylcholine transporter, a novel, specific marker of cholinergic terminals, were used to investigate the nature of these presynaptic receptors. These studies have revealed that M-2 is located in cholinergic and non-cholinergic terminals. This is the first direct anatomical evidence that suggests that M-2 may indeed function as a cholinergic autoreceptor in the hippocampus. The distribution of the M-2 receptor in noncholinergic terminals also suggests functional roles for Mp as a presynaptic heteroreceptor. (C) 2000 Published by Elsevier Science Ireland Ltd. All rights reserved.
引用
收藏
页码:182 / 186
页数:5
相关论文
共 20 条
[1]   CHOLINERGIC MODULATION OF SYNAPTIC INHIBITION IN THE GUINEA-PIG HIPPOCAMPUS INVITRO - EXCITATION OF GABAERGIC INTERNEURONS AND INHIBITION OF GABA-RELEASE [J].
BEHRENDS, JC ;
TENBRUGGENCATE, G .
JOURNAL OF NEUROPHYSIOLOGY, 1993, 69 (02) :626-629
[2]   Effects of xanomeline, a selective muscarinic receptor agonist, on cognitive function and behavioral symptoms in Alzheimer disease [J].
Bodick, NC ;
Offen, WW ;
Levey, AI ;
Cutler, NR ;
Gauthier, SG ;
Satlin, A ;
Shannon, HE ;
Tollefson, GD ;
Rasmussen, K ;
Bymaster, FP ;
Hurley, DJ ;
Potter, WZ ;
Paul, SM .
ARCHIVES OF NEUROLOGY, 1997, 54 (04) :465-473
[3]   REGIONAL SELECTIVITY OF A GAMMA-AMINOBUTYRIC ACID-INDUCED [H-3] ACETYLCHOLINE-RELEASE SENSITIVE TO INHIBITORS OF GAMMA-AMINOBUTYRIC-ACID UPTAKE [J].
BONANNO, G ;
RAITERI, M .
JOURNAL OF NEUROCHEMISTRY, 1987, 48 (05) :1454-1458
[4]  
BUCKLEY NJ, 1989, MOL PHARMACOL, V35, P469
[5]   ALZHEIMERS-DISEASE - A DISORDER OF CORTICAL CHOLINERGIC INNERVATION [J].
COYLE, JT ;
PRICE, DL ;
DELONG, MR .
SCIENCE, 1983, 219 (4589) :1184-1190
[6]  
DORJE F, 1991, J PHARMACOL EXP THER, V256, P727
[7]   A CONTROLLED TRIAL OF TACRINE IN ALZHEIMERS-DISEASE [J].
FARLOW, M ;
GRACON, SI ;
HERSHEY, LA ;
LEWIS, KW ;
SADOWSKY, CH ;
DOLANURENO, J .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1992, 268 (18) :2523-2529
[8]  
Gilmor ML, 1996, J NEUROSCI, V16, P2179
[9]  
Hajos N, 1998, NEUROSCIENCE, V82, P355
[10]   LIGHT AND ELECTRON-MICROSCOPIC STUDY OF M2 MUSCARINIC ACETYLCHOLINE-RECEPTOR IN THE BASAL FOREBRAIN OF THE RAT [J].
LEVEY, AI ;
EDMUNDS, SM ;
HERSCH, SM ;
WILEY, RG ;
HEILMAN, CJ .
JOURNAL OF COMPARATIVE NEUROLOGY, 1995, 351 (03) :339-356